Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Valeant To Acquire Ortho Dermatologics | Contract Pharma

What are you searching for?

Sign in
Breaking News

Valeant To Acquire Ortho Dermatologics

Second dermatology acquisition in a week for Valeant

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Valeant Pharmaceuticals International will acquire the assets of the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc. (a J&J business) for $345 million. The acquisition, which follows Valeant’s purchase of Sanofi’s Dermik unit earlier this week, includes prescription brands RETIN-A MICRO, ERTACZO, and RENOVA.  Total revenue for the product portfolio was approximately $150 million in 2010.  The transaction is subject to certain closing conditions and regulatory approvals and is expected to be accretive in 2011.

“With the combination of this transaction and other recently announced transactions, Valeant is well on its way to being one of the leading companies in dermatology,” stated J. Michael Pearson, Valeant’s chairman and chief executive officer.  “We believe that dermatology remains an attractive therapeutic area for Valeant and we are pleased to able to add another strong franchise to our growing operations.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters